PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11430933-5	2001	Sulfasalazine and 5-aminosalicylic acid, therapeutic drugs for inflammatory bowel disease, inhibited 5-lipoxygenase activity with an IC(50) of 293 and 970 microM, respectively.	Mesalamine	18-39	arachidonate 5-lipoxygenase	Homo sapiens	101-115	
29550533-1	2018	Three new series of 5-aminosalicylic acid derivatives; series I (14, 16-18), series II (19-30) and series III (31-41) were synthesized as potential dual COX-2/5-LOX inhibitors.	Mesalamine	20-41	arachidonate 5-lipoxygenase	Homo sapiens	159-164	
20948062-1	1996	Mesalazine- a 5 lipoxygenase inhibitor was tried in this open trial on 20 psoriatics.	Mesalamine	0-10	arachidonate 5-lipoxygenase	Homo sapiens	14-28	
2882965-0	1987	Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid.	Mesalamine	110-131	arachidonate 5-lipoxygenase	Homo sapiens	14-28